BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Deals

  Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results

  Definitive merger agreement with Forte Biosciences announced February 19, 2020

  February 27, 2020

   · 

  6 min read
• Policy

  Stellar Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

  Stellar Health, a leading organization in value-based care, announced, that the Stellar Health Web Application and supporting infrastructure has earned Certified status for information security by HITRUST.

  February 27, 2020

   · 

  2 min read
• FDA

  Biohaven’s NURTEC™ ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults

  -Biohaven Pharma Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine in adults.

  February 27, 2020

   · 

  11 min read
• Business

  Trovagene Announces Fourth Quarter and Full-Year 2019 Results

  Trovagene, Inc. (Nasdaq: TROV), today announced company highlights and financial results for the fourth quarter and full-year ended December 31, 2019.

  February 27, 2020

   · 

  12 min read
• Business

  Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results

  Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2019 .

  February 27, 2020

   · 

  16 min read
• Business

  Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results

  Five Prime Therapeutics, Inc. (NASDAQ: FPRX), , today announced results for the fourth quarter and year ended December 31, 2019, in addition to providing an update on the company’s recent activities.

  February 27, 2020

   · 

  15 min read
• Business

  Tricida Announces Fourth Quarter and Full-Year 2019 Financial Results

  Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the fourth quarter and full-year ended December 31, 2019.

  February 27, 2020

   · 

  10 min read
• Business

  Acceleron Reports Fourth Quarter and Full Year 2019 Operating and Financial Results

  Acceleron Pharma Inc today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2019.

  February 27, 2020

   · 

  11 min read
• Business

  Dicerna™ Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

  Dicerna Pharmaceuticals. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today reported financial results for the fourth quarter and full year ended Dec. 31, 2019, and provided a corporate update.

  February 27, 2020

   · 

  16 min read
• Business

  Aimmune Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Recent Operational Highlights

  Aimmune Therapeutics, Inc. (Nasdaq: AIMT), today announced financial results for the fourth quarter and full year 2019.

  February 27, 2020

   · 

  19 min read